Search clinical trials for: Direct oral anticoagulation

Total 23609 results

Seoul National University Hospital
Medtronic Korea Co., Ltd.; Samjin Pharmaceutical Co., Ltd.

Not yet recruiting

Pill-in-the-POCKET Oral Anticoagulation Strategy After AF Catheter Ablation (POCKET-OAC)

Atrial Fibrillation
University of Utah
National Heart, Lung, and Blood Institute (NHLBI)

Not yet recruiting

Learning Theory Patient Education for Anticoagulants

Knowledge, Attitudes, Practice
University of Giessen

Recruiting

Urin-based Point-of-Care Testing for Direct Oral Anticoagulants in Stroke Patients (UPTURN)

Stroke

Germany
Insel Gruppe AG, University Hospital Bern

Not yet recruiting

Early Closure of Left Atrial Appendage for Patients With Atrial Fibrillation and Ischemic Stroke Despite Anticoagulation Therapy (ELAPSE)

Ischemic Stroke | Atrial Fibrillation
Centre Hospitalier Universitaire de Nīmes

Recruiting

Anticoagulation Therapy in Non-device-related Intra-cardiac Thrombus (ARGONAUT)

Heart Failure | STEMI | Intracardiac Thrombus

France, Réunion
Mansoura University

Not yet recruiting

Efficacy of Direct Oral Anticoagulants as a Prophylactic Anticoagulation of Catheter Induced Thrombosis

Anticoagulants; Increased
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

DIrect Oral Anticoagulation and mechaNical Aortic Valve (DIAMOND)

Aortic Valve Disease

France
iOMEDICO AG
AstraZeneca

Recruiting

Acalabrutinib in Patients With Chronic Lymphocytic Leukemia With Direct Oral Anticoagulation (CICERO) (CICERO)

CLL

Germany
Sunnybrook Health Sciences Centre

Recruiting

Anticoagulation Therapy Timing in Atrial Fibrillation After Acute and Chronic Subdural Hematoma (ATTAACH)

Atrial Fibrillation | Subdural Hematoma

Canada
Hospital Universitario La Fe

Recruiting

Uninterrupted Direct-acting Oral Anticoagulation in Patients Undergoing Transradial Percutaneous Coronary Procedures (DOAC-NOSTOP)

Coronary Artery Disease | Bleeding | Direct Acting Anticoagulant Adverse Reaction

Spain, Italy
Takeda
Takeda Development Center Americas, Inc.

Recruiting

A Study of TAK-330 for Reversal of Direct Oral Factor Xa Inhibitor-induced Anticoagulation

Coagulation Disorder

United States, Spain, Belgium, France, Netherlands
Medical University of Vienna

Recruiting

Early Surgical Fixation of Low-Velocity Hip Fractures in Patients With Direct Oral Anticoagulation

Hip Fractures

Austria
University Hospital, Geneva
Sunnybrook Health Sciences Centre

Not yet recruiting

The API-CALF Study: Apixaban to Treat Calf Vein Thrombosis (API-CALF)

Deep Vein Thrombosis
Zuyderland Medisch Centrum

Not yet recruiting

Comparison Between Direct Oral Anticoagulation (DOAC) Interruption and DOAC Continuation in Patients Undergoing Elective Invasive Coronary Angiography or Percutaneous Coronary Intervention (SLIM-2)

Coronary Artery Disease | Atrial Fibrillation | Anticoagulants
University of Birmingham
Royal United Hospitals Bath NHS Foundation Trust; Cimar

Recruiting

STOPping Anticoagulation for Isolated or Incidental Subsegmental Pulmonary Embolism (STOPAPE)

Subsegmental Pulmonary Embolism Nos

United Kingdom
University of Birmingham
University of Oxford; University Hospital Birmingham NHS Foundation Trust; London... and other collaborators

Recruiting

Preventing Stroke, Premature Death and Cognitive Decline in a Broader Community of Patients With Atrial Fibrillation (DaRe2THINK)

Atrial Fibrillation

United Kingdom
University Hospital Tuebingen
Heart and Diabetes Center North Rhine-Westphalia

Recruiting

Point-of-Care Testing of Coagulation in Patients Treated With Direct Oral Anticoagulants Extended (POCT-DOAC ext)

Anticoagulation With Direct Oral Anticoagulants

Germany
AHEPA University Hospital
Theagenio Cancer Hospital

Recruiting

Management of Atrial Fibrillation in Patients With Cancer (MAFIC Study) (MAFIC)

Cancer | Atrial Fibrillation

Greece
Hospital Álvaro Cunqueiro

Recruiting

Retrospective Observational Registry of Patients With Atrial Fibrillation From Vigo´s Health Area (CardioCHUVI-AF)

Atrial Fibrillation

Spain
Population Health Research Institute
Hamilton Health Sciences Corporation

Recruiting

The Direct Oral Anticoagulation Versus Vitamin K Antagonist After Cardiac Surgery Trial (DANCE)

Bleeding Post Cardiac Surgery | Indication for Anticoagulation

Canada
University College, London

Recruiting

OPTIMAS: OPtimal TIMing of Anticoagulation After Acute Ischaemic Stroke : a Randomised Controlled Trial (OPTIMAS)

Atrial Fibrillation | Stroke, Acute

United Kingdom
Herlev and Gentofte Hospital
Danish Society of Cardiology

Recruiting

The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Venous Thromboembolism (DANNOAC-VTE) (DANNOAC-VTE)

Deep Vein Thrombosis | Pulmonary Embolism

Denmark
Herlev and Gentofte Hospital
Danish Society of Cardiology

Recruiting

The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Atrial Fibrillation (DANNOAC-AF)

Atrial Fibrillation | Atrial Flutter

Denmark
Centre Hospitalier Universitaire de Nīmes
Medtronic

Recruiting

Anticoagulation Alone Versus Anticoagulation and Aspirin Following Transcatheter Aortic Valve Interventions (1:1) (AVATAR)

Transcatheter Aortic Valve Replacement

France
GUALTIERO PALARETI
Arianna Anticoagulazione Foundation

Recruiting

START-Register: Survey on Anticoagulated Patients Register

Atrial Fibrillation | Venous Thromboembolism | Heart Valve Diseases or Prosthesis

Italy
St. Paul's Hospital, Canada

Active, not recruiting

The Safety of Non-vitamin K Oral Anticoagulants Compared to Warfarin Early After Cardiac Surgery

Atrial Fibrillation

Canada
St. Antonius Hospital

Active, not recruiting

Periprocedural Continuation Versus Interruption of Oral Anticoagulant Drugs During Transcatheter Aortic Valve Implantation (POPular PAUSE TAVI)

Myocardial Infarction | Stroke | Bleeding | Aortic Valve Stenosis | Aortic Valve Disease | Thrombosis Embolism | Vascular Complications

Netherlands, Ireland, Belgium, Denmark, Italy, Luxembourg
Palak Shah
Abbott Medical Devices

Completed

Evaluation of the Hemocompatibility of the Direct Oral Anti-Coagulant Apixaban in Left Ventricular Assist Devices (DOAC LVAD)

Heart Failure

United States
Insel Gruppe AG, University Hospital Bern

Completed

Early Versus Late Initiation of Direct Oral Anticoagulants in Post-ischaemic Stroke Patients With Atrial fibrillatioN (ELAN): an International, Multicentre, Randomised-controlled, Two-arm, Assessor-blinded Trial (ELAN)

Ischaemic Stroke

Belgium, Ireland, Israel, Germany, India, United Kingdom, Austria, Switzerland, Finland, Norway, Italy, Portugal, Slovakia, Japan, Greece
CHAD

Terminated

The Portuguese Survey on Anticoagulated Patients Register (START-Portugal-Register) (START-Portugal)

Atrial Fibrillation | Venous Thromboembolism | Heart Valve Diseases or Prosthesis

Portugal
University of California, San Francisco
Patient-Centered Outcomes Research Institute; Kaiser Permanente

Completed

Anticoagulation Length of ThErapy and Risk of New Adverse evenTs In Venous thromboEmbolism Study (ALTERNATIVE)

Venous Thromboembolism | Anticoagulants and Bleeding Disorders

United States
Kansas City Heart Rhythm Institute
Kansas City Heart Rhythm Research Foundation

Completed

DOACs for Stroke Prevention Post Ventricular Tachycardia Ablation (STROKE-VT)

Stroke | Ventricular Tachycardia | Premature Ventricular Contraction

United States, India
Doasense GmbH
Clinical Research Services, Mannheim, Germany; Institute Medical Statistics... and other collaborators

Completed

In Vitro Diagnostic Test for DOAC in Urine (PADOASU)

Anticoagulant Therapy

Germany
Alexion Pharmaceuticals
Population Health Research Institute; Portola Pharmaceuticals, LLC (a wholly...

Completed

A Study in Participants With Acute Major Bleeding to Evaluate the Ability of Andexanet Alfa to Reverse the Anticoagulation Effect of Direct and Indirect Oral Anticoagulants (Extension Study)

Bleeding

United States, Belgium, Canada, France, Germany, Japan, Netherlands, Spain, United Kingdom
R&D Cardiologie
St. Antonius Hospital

Unknown

What is the Optimal antiplatElet and Anticoagulant Therapy in Patients With Oral Anticoagulation Undergoing revasculariSaTion 2. (WOEST 2)

Myocardial Infarction | Stroke | Bleeding | Acute Coronary Syndromes | Coronary Artery Diseases | Atrial Fibrillations | Heart Valve Prostheses

Belgium, Netherlands
Fundación para la Investigación del Hospital Clínico...

Completed

Periprocedural Direct Oral Anticoagulant Management (RA-ACOD)

Periprocedural Complication

Spain
Biotronik, Inc.

Terminated

Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk (IMPACT)

Stroke | Atrial Fibrillation | Atrial Flutter | Major Bleeding | Embolism, Systemic Arterial

United States, Canada, United Kingdom, Denmark, Germany, Australia
AiCure
Montefiore Medical Center

Completed

Using Artificial Intelligence to Measure and Optimize Adherence in Patients on Anticoagulation Therapy.

Stroke

United States
University Hospital Tuebingen
Heart and Diabetes Center North Rhine-Westphalia

Completed

Point-of-Care Testing of Coagulation in Patients Treated With Direct Oral Anticoagulants 2 (POCT-DOAC 2)

Anticoagulation With Direct Oral Anticoagulants
University Hospital Tuebingen
Heart and Diabetes Center North Rhine-Westphalia

Completed

Point-of-Care Testing of Coagulation in Patients Treated With Direct Oral Anticoagulants 1 (POCT-DOAC 1)

Anticoagulation With Direct Oral Anticoagulants
Brazilian Clinical Research Institute
Alliança Diagnostic

Not yet recruiting

Anti-inflammatory and Anti-thrombotic Therapy With colcHicine and Low Dose Rivaroxaban for Major Adverse Cardiovascular Events Reduction in Ischemic Stroke (ARCHIMEDES)

Ischemic Stroke
VarmX B.V.

Recruiting

Single Dose Trial of VMX-C001 in Healthy Subjects With and Without FXa Direct Oral Anticoagulant

Coagulation Disorder

Netherlands
7 Hills Pharma, LLC

Not yet recruiting

A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

Melanoma | Kidney Cancer | Renal Cell Carcinoma | Hepatocellular Carcinoma | Colorectal Cancer | NSCLC | Non Small Cell Lung Cancer | Skin Cancer | Metastasis | Advanced Solid Tumor | Advanced Cancer | Renal Cell Cancer | Hepatocellular Cancer | Mismatch Repair Deficiency | Pleural Mesothelioma | MSI-High | Anaplastic Lymphoma... and other conditions

United States
Peking Union Medical College Hospital
Xiangya Hospital of Central South University; Ruijin Hospital; China-Japan Friendship...

Recruiting

The Study of Monitoring and Dosing Guidance of Direct Oral Anticoagulants Based on Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics

Pulmonary Embolism

China
Copka Sonpashan

Not yet recruiting

Combining Transcranial Direct Current Stimulation With Intermittent Oral to Esophageal Tube for Stroke-related Dysphagia

Stroke
Walton Centre NHS Foundation Trust
University of Liverpool; National Institute for Health Research, United Kingdom

Not yet recruiting

Timing to Restart Direct Oral Anticoagulants After Traumatic Intracranial Haemorrhage (RESTARTtlCrH)

Traumatic Intracranial Haemorrhage
James Tarbox, MD
Texas Tech University Health Sciences Center

Recruiting

Penicillin Allergy Delabeling After a One-Dose Versus Two-Dose Graded Direct Oral Challenge

Penicillin Allergy

United States
Inhibrx, Inc.

Not yet recruiting

INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC

Head and Neck Squamous Cell Carcinoma (HNSCC)
Gia Dinh People Hospital

Not yet recruiting

MEdication Counselling Models for Outpatient oRal antIcoaguLation (MEMORIAL)

Anticoagulants; Circulating, Hemorrhagic Disorder
Zeng Changhao
The First Affiliated Hospital of Zhengzhou University

Recruiting

Transcranial Direct Current Stimulation Combined With Intermittent Oral to Esophageal Tube on Dysphagia (IOE+JLCJ-S)

Cerebral Infarction

Korea, Republic of

Search clinical trials for: Direct oral anticoagulation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Jordan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations